
Rockwell Medical, Inc.: updates and filings
Price
$5.82
November 20, 2026Market cap $23M
What Ploutos Investor adds for Rockwell Medical
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 12, 2026next Feb 12, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
June 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 12, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 12, 2026Results of operationsForm8-K
- Nov 3, 2026Material agreement entered, unregistered sale of shares, Regulation FD disclosureForm8-K
- Aug 13, 2026Regulation FD disclosureForm8-K
- Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 13, 2026Results of operationsForm8-K
- Jul 20, 2026Other material eventsForm8-K
- Jun 29, 2026Change to shareholders' rights, amended articles or bylawsForm8-K
- Jun 15, 2026Shareholder voteForm8-K
- May 11, 2026Additional annual meeting materialFormDEFA14A
- May 8, 2026Delisting noticeForm8-K
- May 7, 2026Regulation FD disclosureForm8-K
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 7, 2026Results of operationsForm8-K
- Apr 30, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 30, 2026Annual meeting proxy statementFormDEF 14A
- Apr 20, 2026Preliminary proxy statementFormPRE 14A
- Mar 26, 2026Regulation FD disclosureForm8-K
- Mar 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 26, 2026Results of operationsForm8-K
- Jan 20, 2026Results of operationsForm8-K
- Jan 5, 2026Other material eventsForm8-K
- Nov 18, 2025Officer or director changeForm8-K
- Nov 14, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 12, 2025Regulation FD disclosureForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 12, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 12, 2026 | 8-K | Results of operations | Document |
| Nov 3, 2026 | 8-K | Material agreement entered, unregistered sale of shares, Regulation FD disclosure | Document |
| Aug 13, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 13, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 13, 2026 | 8-K | Results of operations | Document |
| Jul 20, 2026 | 8-K | Other material events | Document |
| Jun 29, 2026 | 8-K | Change to shareholders' rights, amended articles or bylaws | Document |
| Jun 15, 2026 | 8-K | Shareholder vote | Document |
| May 11, 2026 | DEFA14A | Additional annual meeting material | Document |
| May 8, 2026 | 8-K | Delisting notice | Document |
| May 7, 2026 | 8-K | Regulation FD disclosure | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 7, 2026 | 8-K | Results of operations | Document |
| Apr 30, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 30, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 20, 2026 | PRE 14A | Preliminary proxy statement | Document |
| Mar 26, 2026 | 8-K | Regulation FD disclosure | Document |
| Mar 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 26, 2026 | 8-K | Results of operations | Document |
| Jan 20, 2026 | 8-K | Results of operations | Document |
| Jan 5, 2026 | 8-K | Other material events | Document |
| Nov 18, 2025 | 8-K | Officer or director change | Document |
| Nov 14, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 12, 2025 | 8-K | Regulation FD disclosure | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jul 24, 1997.
The full analysis
What do Rockwell Medical's filings show?
The filings are where every one of Rockwell Medical's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.